Close
4

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Company profile for Polpharma

  • Webinars & Exhibitions

  • Alendronate Sodium

  • Apixaban

  • Baclofen

  • Dapagliflozin

  • Dapagliflozin Propanediol Monohydrate

  • Empagliflozin

  • Enzalutamide

  • Hydrochlorothiazide

  • Isavuconazonium Sulfate

  • Linagliptin

  • Palbociclib

  • Pentoxifylline

  • Piracetam

  • Rivaroxaban

  • Tadalafil

  • Ticagrelor

  • Trametinib

  • Zoledronic Acid

  • Cryogenic Reactions

  • API Scale-Up

  • API Development Services

  • API Scale-Up Capabilities

PharmaCompass

Virtual Booth Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Related CompaniesRelated Companies
Polpharma API. European CDMO partner and API manufacturer since 1951. Poland-based CDMO and API producer, delivering products to pharmaceutical companies worldwide. Aiming at the continuous development of Polpharma and caring for the future of patients, business partners and our employees, we are launching a specialized facility for the R&D and Production of HPAPI with an OEL value of 10 ng/m3 (OEB 6). The HP API investment includes separate process laboratories (PDL), analytical laboratories (ADL) with the possibility of performing QC analyses, and a GMP kilo-lab production line with volume up to 1.5 kg with potential volume increase.
Polpharma API
Polpharma
Poland Flag
Country
Country
Poland
Address
Address
Pelplińska 19, 83-200 Starogard Gdański
Telephone
Telephone
+48 585631600
Twitter
Twitter
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY